Reuters exclusively reports coronavirus outbreak delays Carlyle’s Atotech IPO

Reuters exclusively reported that buyout firm Carlyle Group has delayed the U.S. initial public offering (IPO) of its German specialty chemicals group Atotech over concern that the coronavirus outbreak would negatively impact the valuation it could achieve with investors. Carlyle’s decision highlights the uncertainty that the spread of the virus in China and around the world has brought to financial markets.